243 related articles for article (PubMed ID: 30142184)
1. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
Mori S; Arima N; Ito M; Fujiyama S; Kamo Y; Ueki Y
PLoS One; 2018; 13(8):e0203084. PubMed ID: 30142184
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate-associated nonalcoholic fatty liver disease with transaminitis in rheumatoid arthritis.
Sakthiswary R; Chan GY; Koh ET; Leong KP; Thong BY
ScientificWorldJournal; 2014; 2014():823763. PubMed ID: 24971392
[TBL] [Abstract][Full Text] [Related]
3. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate Hepatotoxicity in Rheumatoid Arthritis: An Analysis of the Physicians' Policy.
Anvari B
Curr Rheumatol Rev; 2020; 16(1):67-73. PubMed ID: 31244428
[TBL] [Abstract][Full Text] [Related]
5. "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?".
García DS; Saturansky EI; Poncino D; Martínez-Artola Y; Rosenberg S; Abritta G; Ascimani-Peña C; Cravero A
Ann Hepatol; 2019; 18(5):765-769. PubMed ID: 31105018
[TBL] [Abstract][Full Text] [Related]
6. Significance of liver biopsy for the evaluation of methotrexate-induced liver damage in patients with rheumatoid arthritis.
Osuga T; Ikura Y; Kadota C; Hirano S; Iwai Y; Hayakumo T
Int J Clin Exp Pathol; 2015; 8(2):1961-6. PubMed ID: 25973089
[TBL] [Abstract][Full Text] [Related]
7. Rare incidence of methotrexate-specific lesions in liver biopsy of patients with arthritis and elevated liver enzymes.
Quintin E; Scoazec JY; Marotte H; Miossec P
Arthritis Res Ther; 2010; 12(4):R143. PubMed ID: 20637063
[TBL] [Abstract][Full Text] [Related]
8. Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms.
Ezhilarasan D
Toxicology; 2021 Jun; 458():152840. PubMed ID: 34175381
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study.
Hakamata J; Hashiguchi M; Kaneko Y; Yamaoka K; Shimizu M; Maruyama J; Takeuchi T; Mochizuki M
Mod Rheumatol; 2018 Jul; 28(4):611-620. PubMed ID: 29252093
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice.
Karlsson Sundbaum J; Eriksson N; Hallberg P; Lehto N; Wadelius M; Baecklund E
Int J Rheum Dis; 2019 Jul; 22(7):1226-1232. PubMed ID: 31012257
[TBL] [Abstract][Full Text] [Related]
11. Incidence, predictive factors and severity of methotrexate-related liver injury in rheumatoid arthritis: a longitudinal cohort study.
Mori S; Arima N; Ito M; Ueki Y; Abe Y; Aoyagi K; Fujiyama S
Rheumatol Adv Pract; 2020; 4(2):rkaa020. PubMed ID: 33134809
[TBL] [Abstract][Full Text] [Related]
12. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
[TBL] [Abstract][Full Text] [Related]
13. Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
Humphreys JH; Warner A; Costello R; Lunt M; Verstappen SMM; Dixon WG
Ann Rheum Dis; 2017 Sep; 76(9):1509-1514. PubMed ID: 28341765
[TBL] [Abstract][Full Text] [Related]
14. Hepatic failure in a patient with rheumatoid arthritis treated with methotrexate: A case report.
Miyata M; Ishiwata S; Kuroda M; Tasaki K; Migita K; Ohira H
Medicine (Baltimore); 2023 Jan; 102(4):e32711. PubMed ID: 36705384
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: A cross-sectional controlled study with real-time two-dimensional shear wave elastography.
Erre GL; Cadoni ML; Meloni P; Castagna F; Mangoni AA; Piga M; Passiu G; Carru C; Zinellu A; Vidili G
Eur J Intern Med; 2019 Nov; 69():57-63. PubMed ID: 31474422
[TBL] [Abstract][Full Text] [Related]
16. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune hepatitis after long-term methotrexate therapy for rheumatoid arthritis.
Moreno-Otero R; García-Buey L; García-Sanchez A; Trapero-Marugán M
Curr Drug Saf; 2011 Jul; 6(3):197-200. PubMed ID: 22122395
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis.
Fathi NH; Mitros F; Hoffman J; Straniero N; Labreque D; Koehnke R; Furst DE
J Rheumatol; 2002 Oct; 29(10):2092-8. PubMed ID: 12375317
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate Hepatotoxicity and the Impact of Nonalcoholic Fatty Liver Disease.
Shetty A; Cho W; Alazawi W; Syn WK
Am J Med Sci; 2017 Aug; 354(2):172-181. PubMed ID: 28864376
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis B.
Tang KT; Hung WT; Chen YH; Lin CH; Chen DY
Sci Rep; 2016 Mar; 6():22387. PubMed ID: 26928373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
